NCT04069117View on ClinicalTrials.gov

Follicular Synchronization in PCOS Patients Undergoing ICSI

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

February 20, 2022

Study Completion Date

February 20, 2022

Conditions
Polycystic Ovarian Syndrome
Interventions
DRUG

letrozole 2.5mg (Femara; Novartis Pharma Services, Basel, Switzerland)

letrozole /antagonist protocol

Trial Locations (1)

050

Faculty of Medicine, Al Mansurah

All Listed Sponsors
lead

Mansoura University Hospital

OTHER

NCT04069117 - Follicular Synchronization in PCOS Patients Undergoing ICSI | Biotech Hunter | Biotech Hunter